Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): A phase II study

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 3053-3056

  Bianco, Vincenzo ^a   Rozzi, Antonio ^a   Tonini, Giuseppe ^b   Santini, Daniele ^b   Magnolfi, Emanuela ^a   Vincenzi, Bruno ^b   D'Angelillo, Rolando ^b   Marchei, Paolo ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c NONE   (Italy)

Author keywords

Elderly; Gemcitabine; Non small cell lung cancer (NSCLC)

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE;

AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; GERIATRIC PATIENT; HISTOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; QUALITY OF LIFE;

EID: 0036765689     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG and Edwards BK: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93(11): 824-42, 2001.
2. Lee-Chiong TL Jr and Matthay RA: Lung cancer in the elderly patient. Clin Chest Med 14(3): 453-78, 1993.
3. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46(1): 5-27, 1996.
4. Zanetti R, Buiatti E, Federico M and Micheli A: Fatti e cifre dei tumori in Italia. Il Pensiero Scientifico: Roma, 1998.
5. Yellen SB, Cella DF and Leslie WT: Age and clinical decision making in oncology patients. J Natl Cancer Inst 86(23): 1766-70, 1994.
6. Festen J: Lung cancer therapy in the elderly. Eur J Cancer 27(12): 1544-5, 1991.
7. Manegold C: Treatment of elderly patients with non-small cell lung cancer. Oncology (Huntingt) 15(3 Suppl 6): 46-51, 2001.
8. Gridelli C: Chemotherapy of advanced non-small cell lung cancer in the elderly: an update. Crit Rev Oncol Hematol 35(3): 219-25, 2000.
9. Rinaldi M, De Marinis F, Ardizzoni A et al: Correlation between age and prognosis in patients with advanced Non Small Cell Lung Cancer (NSCLC) treated with cisplatin (CDDP) containing chemotherapy: retrospective multicenter study. Ann Oncol 5(suppl 8): 583, 1994.
10. Abratt RP, Bezwoda WR, Falkson G, Goedhals L, Hacking D and Rugg TA: Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study. J Clin Oncol 12(8): 1535-40, 1994.
11. Newell GR, Spitz MR and Sider JG: Cancer and age. Semin Oncol 16(1): 3-9, 1989.
12. Lee-Chiong TL Jr and Matthay RA: Lung cancer in the elderly patient. Clin Chest Med 14(3): 453-78, 1993.
13. AA VV: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst 91(1): 66-72, 1999.
14. Shepherd FA, Abratt RP, Anderson H, Gatzemeier U, Anglin G and Iglesias J: Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol 24(2 Suppl 7): S7-50-S7-55, 1997.
15. Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Algeri R, Bonifazi V, Fioretto ML, Orlandini C and Conte PF: Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study. Lung Cancer 27(2): 75-80, 2000.
16. Gatzemeier U, Shepherd FA, Le Chevalier T, Weynants P, Cottier B, Groen HJ, Rosso R, Mattson K, Cortes-Funes H, Tonato M, Burkes RL, Gottfried M and Voi M: Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer 32A(2): 243-8+, 1996.
17. Altavilla G, Adamo V, Buemi B, Marabello G, Maisano R, Lupo G, Bene A and Bellocco G: Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer. Anticancer Res 20(5C): 3675-8, 2000.
18. Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, Nicholson M, Milroy R, Maughan TS, Falk SJ, Bond MG, Burt PA, Connolly CK, Mclllmurray MB and Carmichael J: Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-small Cell Lung Cancer. Br J Cancer 83(4): 447-53, 2000.